Audit Microcontrols
Linearity Set Audit MicroControls Hemoglobin A1c (HbA1c) 5 X 0.8 mL
PRODUCT HIGHLIGHTS
- The Linearity FLQ HbA1c is an IVD device consisting of 5 levels of liquid material and additives in human based serum
- MicroControls Linearity FLQ HbA1c is intended to simulate human patient samples for use in determining linearity, calibration verification, and the verification of reportable range for the following analyte HbA1c
Fast Delivery
Auto Delivery , Free Shipping For $100 Above Products
Item | Description | Quantity | Price |
---|---|---|---|
K761M-5
![]() |
LINEARITY SET, MICRO CONTROL FLQ HBA1C D/S Ships directly from the manufacturer. Additional shipping charges may apply.This Item is non-returnable & non-refundable |
1 Each |
List Price:$627.99 Price:$607.99 You save $20.00 Add To Cart
|

Description
The Audit MicroControls Linearity FLQ Hemoglobin A1c (HbA1c) Set is designed to support accurate calibration and verification in diabetes management testing. This frozen liquid control set simulates human patient samples and includes five distinct levels (A–E) to confirm linearity, calibration verification, and the reportable range of HbA1c assays. Developed with human-based serum, it ensures reliable and consistent results for clinical immunoassay applications.
Key Features:
-
Provides five levels (A–E) for calibration verification and linearity testing
-
Simulates human patient samples for accurate HbA1c assay performance checks
-
Intended for use in immunoassay applications for diabetes management
-
Frozen liquid form for extended stability
-
Supports verification of the reportable range for HbA1c results
Specifications:
-
Manufacturer #: K761M-5
-
Brand: Audit MicroControls
-
Manufacturer: Audit Microcontrols
-
Application: Linearity Set
-
Container Type: Vial
-
Form: Frozen Liquid
-
Levels: A, B, C, D, E
-
Specialty: Immunoassay
-
Test Category: Diabetes
-
Test Name: Hemoglobin A1c (HbA1c)
-
Test Type: Diabetes Management
-
Volume: 5 x 0.8 mL
-
UNSPSC Code: 41116122
-
Product Dating: McKesson acceptable dating (≥ 90 days)